scholarly article | Q13442814 |
P356 | DOI | 10.3109/10428194.2012.745072 |
P698 | PubMed publication ID | 23127115 |
P2093 | author name string | Xin Wang | |
Xiao Lv | |||
P2860 | cites work | Expression cloning of the murine and human interleukin 9 receptor cDNAs | Q24292843 |
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease | Q33183105 | ||
Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma | Q33184751 | ||
IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development | Q33924669 | ||
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma | Q33962334 | ||
Interleukin 9 promotes influx and local maturation of eosinophils | Q34513037 | ||
Mast cells are essential intermediaries in regulatory T-cell tolerance | Q34559099 | ||
The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. | Q35105032 | ||
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells | Q35849172 | ||
Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism | Q36658059 | ||
IL-9 as a mediator of Th17-driven inflammatory disease | Q37292816 | ||
IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells | Q37293226 | ||
Cellular sources and immune functions of interleukin-9 | Q37309989 | ||
The Germinal centre-derived lymphomas seen through their cellular microenvironment. | Q37432242 | ||
Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses. | Q37574566 | ||
Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9. | Q39557718 | ||
Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers | Q39896301 | ||
Interleukin-9 and -13 inhibit spontaneous and corticosteroid induced apoptosis of normal airway epithelial cells | Q39917561 | ||
Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma. | Q40625623 | ||
MAP kinase activation by interleukin-9 in lymphoid and mast cell lines | Q40660999 | ||
Characterization of a novel human anaplastic large cell lymphoma cell line tumorigenic in SCID mice | Q40743100 | ||
Specificity of interleukin-2 receptor gamma chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway | Q40757512 | ||
Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma | Q41756670 | ||
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients | Q43411892 | ||
Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study | Q44227245 | ||
IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor | Q44368615 | ||
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. | Q44453951 | ||
IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice | Q44890588 | ||
Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. | Q46726807 | ||
IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. | Q51954200 | ||
Interleukin-9 stimulatesin vitro growth of mouse thymic lymphomas | Q57194441 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1367-1372 | |
P577 | publication date | 2012-12-05 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | The role of interleukin-9 in lymphoma | |
P478 | volume | 54 |
Q40503744 | A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways |
Q26752374 | Cytokine-Induced Modulation of Colorectal Cancer |
Q39016585 | Evaluation of the T helper 17 cell specific genes and the innate lymphoid cells counts in the peripheral blood of patients with the common variable immunodeficiency |
Q89725109 | IL-9 and Th9 Cells in Tumor Immunity |
Q34624383 | Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges |
Q48168109 | Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. |
Q89613150 | Janus or Hydra: The Many Faces of T Helper Cells in the Human Tumour Microenvironment |
Q58087559 | Minimum degree of overlap between IL-9R and IL-2R on human T lymphoma cells: A quantitative CLSM and FRET analysis |
Q36800335 | Overexpression of IL-9 receptor in diffuse large B-cell lymphoma |
Q35145308 | Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma |
Q37688655 | TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer. |
Search more.